DE2943031A1 - Thiolderivat fuer die zellulitis-behandlung - Google Patents
Thiolderivat fuer die zellulitis-behandlungInfo
- Publication number
- DE2943031A1 DE2943031A1 DE19792943031 DE2943031A DE2943031A1 DE 2943031 A1 DE2943031 A1 DE 2943031A1 DE 19792943031 DE19792943031 DE 19792943031 DE 2943031 A DE2943031 A DE 2943031A DE 2943031 A1 DE2943031 A1 DE 2943031A1
- Authority
- DE
- Germany
- Prior art keywords
- thiol
- hydrogen
- thiol derivative
- treatment
- cellulite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000011282 treatment Methods 0.000 title claims description 17
- 150000003573 thiols Chemical class 0.000 title claims description 13
- 206010007882 Cellulitis Diseases 0.000 title 1
- 208000035484 Cellulite Diseases 0.000 claims description 14
- 206010049752 Peau d'orange Diseases 0.000 claims description 14
- 230000036232 cellulite Effects 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- -1 2-thiol-propionamide-acetic acid Chemical compound 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 229910052783 alkali metal Chemical group 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- WODILIQMLYQCFG-UHFFFAOYSA-N 3-thiophen-2-ylpropanamide Chemical compound NC(=O)CCC1=CC=CS1 WODILIQMLYQCFG-UHFFFAOYSA-N 0.000 claims 1
- 229910052784 alkaline earth metal Chemical group 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 claims 1
- 239000000829 suppository Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT29292/78A IT1101261B (it) | 1978-10-31 | 1978-10-31 | Derivato tiolico per il trattamento della cellulite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2943031A1 true DE2943031A1 (de) | 1980-05-14 |
Family
ID=11226698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792943031 Withdrawn DE2943031A1 (de) | 1978-10-31 | 1979-10-24 | Thiolderivat fuer die zellulitis-behandlung |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE874915A (it) |
| DE (1) | DE2943031A1 (it) |
| FR (1) | FR2440355A1 (it) |
| GB (1) | GB2033748A (it) |
| IT (1) | IT1101261B (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2750332B1 (fr) * | 1996-06-28 | 1998-09-11 | Sincholle Daniel Paul | Composition pour la prevention et le traitement topique de la cellulite |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470M (fr) * | 1962-03-13 | 1964-04-20 | Mead Johnson & Co | Composition thérapeutique. |
| FR1491204A (fr) * | 1962-08-10 | 1967-08-11 | Santen Pharmaceutical Co Ltd | Procédés pour la préparation des alpha-et beta mercaptopropionylglycocolle et de leurs dérivés |
-
1978
- 1978-10-31 IT IT29292/78A patent/IT1101261B/it active
-
1979
- 1979-03-16 BE BE0/194080A patent/BE874915A/xx unknown
- 1979-10-24 DE DE19792943031 patent/DE2943031A1/de not_active Withdrawn
- 1979-10-24 GB GB7936936A patent/GB2033748A/en not_active Withdrawn
- 1979-10-30 FR FR7926904A patent/FR2440355A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2033748A (en) | 1980-05-29 |
| FR2440355A1 (fr) | 1980-05-30 |
| IT1101261B (it) | 1985-09-28 |
| BE874915A (fr) | 1979-07-16 |
| IT7829292A0 (it) | 1978-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3784497T2 (de) | Verfahren und zusammensetzung fuer die erleichterung des rasierens bei der behandlung und verhinderung von pseudofolliculitis barbae. | |
| DE2046119A1 (de) | Mitte) zur Behandlung der Akne | |
| DE3506576A1 (de) | Dermatologische zusammensetzung | |
| DE3413052A1 (de) | Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen | |
| DE69614375T2 (de) | Dermatologische zubereitung zur behandlung von aktinischen keratosen | |
| DE60018569T2 (de) | Neue Verwendung von hyposmotischen Salzlösungen und darauf basierendes Medikament | |
| DE69934410T2 (de) | Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden | |
| DE3828044A1 (de) | Silbersulfadiazinhaltiges mittel zur lokalen aeusserlichen therapie von herpes labialis, herpes genitalis, herpes corporis, zoster (herpes zoster, windpocken sowie ekzema herpeticatum und verbrennungen 11. und 111. grades im bereich der humanmedizin | |
| DE1804801C3 (de) | Mittel zur Aknebehandlung | |
| DE3038604A1 (de) | Verwendung von polyalkylenglykol zur behandlung von hautkrankheiten | |
| WO1989000853A1 (en) | Agent containing salicylic acid for treating lepidosis | |
| CH662733A5 (de) | Kosmetische praeparate, insbesondere zur nachbehandlung von seborrhoe und akne, sowie verfahren zu ihrer herstellung. | |
| DE69129693T2 (de) | Verwendung von nickel und bromide ionen für die behandlung von psoriasis | |
| DE2943031A1 (de) | Thiolderivat fuer die zellulitis-behandlung | |
| DE1668171A1 (de) | Verfahren zur herstellung von stabilen waessrigen loesungen neuer komplexer organosiliciumverbindungen | |
| DE2828352B2 (de) | Mittel zur Behandlung seborrhoischer Zustände | |
| DE4315866C1 (de) | Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren | |
| DE3830333C1 (en) | Pharmaceutical composition for the treatment of the eruption caused by herpes viruses | |
| DE2117762A1 (de) | Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung | |
| DE3604865C2 (it) | ||
| DE1617532A1 (de) | Wirkstoffkomposition mit durchblutungsfoerdernder Wirkung zur Herstellung von Haar-,Haut- und Koerperpflegemitteln | |
| Bergfeld | Zellteilung und Morphogenese der Vorkeime von Dryopteris filix-mas (L.) Schott in hellroter und blauer Strahlung bei Hemmung der Proteinsynthese | |
| DE1617306A1 (de) | Zahnputzmittel zur Reinigung von Zaehnen und der Verhinderung von Zahnerkrankungen wie Karies oder Zahnfleischentzuendungen | |
| DE4134888C2 (de) | Verwendung eines Ölbades als die Wundheilung fördernder Badezusatz | |
| DE4119170A1 (de) | Mittel gegen neurodermitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |